Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sawsan Salameh"'
Publikováno v:
From Pathophysiology to Treatment of Huntington's Disease ISBN: 9781803554266
From Pathophysiology to Treatment of Huntington's Disease
From Pathophysiology to Treatment of Huntington's Disease
Huntington’s disease (HD) is a progressive, non-curative, autosomal dominant neurodegenerative disease characterized by prominent psychiatric problems, as well as progressive deterioration in both cognitive function and motor control. The success o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e617cddbe568259fac785aead16d05
https://doi.org/10.5772/intechopen.103840
https://doi.org/10.5772/intechopen.103840
Multiple sclerosis (MS) is a central nervous system inflammatory illness that begins with immune system dysregulation and impairs information flow inside the brain as well as between the brain and the rest of the body. The cause of MS is yet unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::344a4490135018d76589068e9a49a4c9
https://doi.org/10.5772/intechopen.105834
https://doi.org/10.5772/intechopen.105834
Autor:
Elliot M. Berry, Fida' Harfoush, Sawsan Salameh, Yousef Najajreh, Nikolaos Grigoriadis, Eithan Kunkes, Jehoshua Katzhendler, Yosefa Avraham, Shira Merchavia, Aviva Ezra, Chana Listman, Lia Vorobeiv
Publikováno v:
Journal of Medicinal Chemistry. 56:1811-1829
Newly synthesized acylethanolamide derivatives oleoyl-L-valinolamide (1), oleoyl-D-valinolamide (2), elaidoyl-L-valinolamide (3), elaidoyl-D-valinolamide (4) stearoyl-L-valinolamide (5), and palmitoyl-L-valinolamide (6) were investigated in mice as a
Publikováno v:
European Journal of Inorganic Chemistry. 2005:2779-2782
This article describes the nickel cluster compound [Ni9L8(OH)6(NH3)4(H2O)8](NO3)4·8H2O, where L represents the anionic form of the ligand 7,8-dihydro-1,2,4-triazolo[4,3-a]pyrimidin-7-one. The structure of the cation of this compound is rather compli
Autor:
Dan Gibson, Ezequiel Wexselblatt, Eylon Yavin, Sawsan Salameh, Aviva Friedman-Ezra, Raji Raveendran
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany). 21(7)
The design of Pt(IV) pro-drugs as anticancer agents is predicated on the assumption that they will not undergo substitution reactions before entering the cancer cell. Attempts to improve the cytotoxic properties of Pt(IV) pro-drugs included the use o
Publikováno v:
European Journal of Inorganic Chemistry; Jul2005, Vol. 2005 Issue 14, p2779-2782, 4p